Company · CIK 0001716947 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Ensysce Biosciences, Inc. · ENSC

Insider activity reported against this company. All insider holders · On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market buys & salesbuys $10.4M · 2sales $0 · 0net $10.4M

Reported at this company — common stock

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Apr 23, 2026 PForm 4 →	Aug 18, 6:06 am EDT	Bob G GowerDirector	908,614	$0.4888	$444,169	916,740	+11,182%	late
Jan 15, 2018 JForm 4 →	Jan 17, 5:39 pm EST	HG Vora Capital Management, LLC10% Owner	375,000	—	—	3,462,500	—	plan?
Jan 15, 2018 JForm 4 →	Jan 17, 5:35 pm EST	A Lorne Weil +1Executive Chairman, Director	172,803	—	—	867,842	—	plan?
Jan 15, 2018 JForm 4 →	Jan 17, 5:26 pm EST	George PengChief Financial Officer	13,251	—	—	87,014	—	plan?
Jan 15, 2018 JForm 4 →	Jan 17, 5:21 pm EST	Eric CarreraSenior Vice President	8,330	—	—	54,701	—	plan?
Jan 15, 2018 JForm 4 →	Jan 17, 5:18 pm EST	Daniel B. Silvers +2Chief Executive Officer, Director	171,832	—	—	1,128,370	—	plan?
Dec 5, 2017 JForm 4 →	Dec 5, 6:57 pm EST	Daniel B. Silvers +2Chief Executive Officer, Director	359,869	—	—	1,300,202	—	plan?
Dec 5, 2017 JForm 4 →	Dec 5, 6:56 pm EST	A Lorne Weil +1Executive Chairman, Director	356,683	—	—	1,000,000	—	plan?
Dec 5, 2017 JForm 4 →	Dec 5, 6:56 pm EST	HG Vora Capital Management, LLC10% Owner	718,750	—	—	2,837,500	—	plan?
Dec 5, 2017 JForm 4 →	Dec 5, 6:56 pm EST	Eric CarreraSenior Vice President	1,465	—	—	63,031	—	plan?
Dec 5, 2017 JForm 4 →	Dec 5, 6:55 pm EST	George PengChief Financial Officer	733	—	—	100,265	—	plan?
Dec 1, 2017 PForm 4 →	Jan 17, 2018, 5:39 pm EST	HG Vora Capital Management, LLC10% Owner	1,000,000	$10.00	$10,000,000	3,837,500	+35.2%	plan? late

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Apr 23, 2026 CForm 4 →	Aug 18, 6:06 am EDT	Bob G GowerDirector	254,307	—	—	289,836	—	late